403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
World Health Organization to supply Libya with medicines
(MENAFN) Libyan hospitals have been supplied with necessary medicines with the help of the German government and the U.S. Office of Foreign Disaster Assistance, as said by The World Health Organization (WHO) on Wednesday.
World Health Organization said that, Libya's hospitals and clinics needed a stable supply of medicine to cure chronic diseases like diabetes, high blood pressure and asthma. Support from the government of Germany guarantees that contingency stocks are obtainable in east, south and west Libya through emergencies.
It also said that, the U.S. Office of Foreign Disaster Assistance is as well funding important medical supplies required by hospitals and clinics that would help out a lot of patients for 3 months.
As a result of years of armed clashes and economic instability, Libyan authorities have been under pressure to supply proper healthcare and education and other necessary services for the people.
World Health Organization said that, Libya's hospitals and clinics needed a stable supply of medicine to cure chronic diseases like diabetes, high blood pressure and asthma. Support from the government of Germany guarantees that contingency stocks are obtainable in east, south and west Libya through emergencies.
It also said that, the U.S. Office of Foreign Disaster Assistance is as well funding important medical supplies required by hospitals and clinics that would help out a lot of patients for 3 months.
As a result of years of armed clashes and economic instability, Libyan authorities have been under pressure to supply proper healthcare and education and other necessary services for the people.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment